Anzeige
Mehr »
Dienstag, 02.09.2025 - Börsentäglich über 12.000 News
Milliardenmarkt Multiple Sklerose: Neue Therapieform könnte alles verändern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
12.08.Lilly-backed scheme aims to help UK improve obesity care
12.08.Novartis two for two as ianalumab scores again
12.08.Bayer buys into KRAS with $1.3bn Kumquat deal
12.08.Apple partners with FuturHealth on weight loss
12.08.IO Bio plans cancer vaccine filing despite trial miss
11.08.FDA starts swift review of GSK antibiotic for gonorrhoea
11.08.MorphoSys takeover delivers phase 3 win for Novartis
11.08.FDA restricts use of bluebird's Skysona gene therapy
11.08.Boehringer back in cancer with Hernexeos approval
11.08.Vinay Prasad returns to FDA
08.08.Iovance cuts staff on slower cell therapy sales growth
08.08.GSK and CureVac settle mRNA patent spat with Pfizer/BioNTech
08.08.Click, Boehringer DTx for schizophrenia passes phase 3 test
07.08.Strand raises $153m for RNA meds, and other bio financings
07.08.FDA makes it easier to set up US manufacturing sites
07.08.England poised to roll out drug for rare eye disease LHON
07.08.Lilly weakens on oral weight-loss drug data
07.08.Pushback against Kennedy's mRNA decision builds
07.08.Jazz gets FDA okay for Chimerix brain cancer drug
07.08.Rumour mill says Novartis may want to buy Avidity
06.08.Bayer's job cull nears 12,000, with more to come
06.08.Meta harvested health data to target ads, jury concludes
06.08.Novo Nordisk weakens again on interim results readout
06.08.New medicines review process under NHS 10-year plan emerges
06.08.RFK Jr cancels $500m in funding for mRNA vaccines